Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05613569 · ClinicalTrials.gov registry record
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
A clinical trial of Lumbosacral Radiculopathy, sponsored by Kolon Life Science.
- Active
- Registry status
- 5
- Enrollment target
- 1
- Study location
NCT05613569 is a study of Lumbosacral Radiculopathy that is active but no longer recruiting, run by Kolon Life Science. The registered enrollment target is 5 participants, below the 78-participant average among 3 other Lumbosacral Radiculopathy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05613569, a study of Lumbosacral Radiculopathy, is active but no longer recruiting, sponsored by Kolon Life Science.
- ACTIVE NOT RECRUITING
- Registry status
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a long-term, 3-year, follow-up study for patients completing the KS-GIG-001-01 Study
Conditions Studied
Interventions
- DRUG KLS-2031
Study Locations (1)
Utah
- Kolon Investigative Site : CenExel JBR - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-07-26 |
| Est. Completion | 2027-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05613569
The ClinicalTrials.gov registry entry for NCT05613569 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 78-participant average among 3 other Lumbosacral Radiculopathy trials with a reported enrollment target (94% lower). The listed sponsor is Kolon Life Science, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lumbosacral Radiculopathy appearing as the primary indexed condition, and to 1 intervention - of which KLS-2031 is the first listed.
NCT05613569 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05613569 about?
NCT05613569 is a clinical study titled "A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study". This is a long-term, 3-year, follow-up study for patients completing the KS-GIG-001-01 Study
What is the current status of trial NCT05613569?
This trial is currently active not recruiting. The enrollment target is 5 participants. The study started on 2022-07-26. Estimated completion is 2027-04-30.
What conditions does trial NCT05613569 study?
This clinical trial studies the following conditions: Lumbosacral Radiculopathy.
What interventions are being tested in trial NCT05613569?
The interventions under investigation include: KLS-2031 (DRUG).
Who is sponsoring clinical trial NCT05613569?
This trial is sponsored by Kolon Life Science, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05613569 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbosacral Radiculopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE
RECRUITING · NA
-
Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
COMPLETED · Phase 2
-
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.